Home/InterVene/Cathy Matthes

CM

Cathy Matthes

CFO

Therapeutic Areas

Cardiovascular Venous Diseases

InterVene Pipeline

Drug	Indication	Phase
Mechanical Thrombectomy System	Venous In-Stent Restenosis (ISR) and Native Vessel Thrombotic Occlusions	Pre-clinical

Leadership Team at InterVene

VP, Quality Assurance, Clinical and Regulatory

VP, Research & Development and Operations

View full InterVene profile